Clinical, Biochemical, and Radiological Profile of Normocalcemic Primary Hyperparathyroidism.


Journal

The Journal of clinical endocrinology and metabolism
ISSN: 1945-7197
Titre abrégé: J Clin Endocrinol Metab
Pays: United States
ID NLM: 0375362

Informations de publication

Date de publication:
01 07 2020
Historique:
received: 12 12 2019
accepted: 08 04 2020
pubmed: 10 4 2020
medline: 3 2 2021
entrez: 10 4 2020
Statut: ppublish

Résumé

The clinical and radiological aspects of normocalcemic hyperparathyroidism (NHPT) are confounded by the differing methods used to rule out secondary hyperparathyroidism and by the small sample size. To assess the clinical, biochemical, and radiological profile of NHPT compared with primary hyperparathyroidism (PHPT) and control subjects. Multicentric cross-sectional study. Outpatient clinic. 47 NHPT, 41 PHPT, and 39 age- and sex-matched control subjects. Calcium metabolism and bone turnover markers (BTMs). Lumbar spine, total hip, femoral neck, one-third distal radius bone mineral density (BMD). Morphometric vertebral fracture (VF) assessed by dual-energy X-ray absorptiometry. NHPT patients had significantly higher parathyroid hormone, 25(OH)-vitamin D levels and lower calcium × phosphorus product than controls (P < .001). Compared with PHPT, the NHPT group had significantly higher 25(OH) vitamin D levels (P = .016). NHPT had BTM levels similar to controls and PHPT. NHPT, PHPT, and controls have similar lumbar spine and femoral neck BMD. NHPT and controls had a similar radial BMD, while patients with PHPT had a lower radial BMD than both patients with NHPT (P = .031) and controls (P < .05). Using the control group as the reference, after adjustment for interacting factors, there was no increase in risk of moderate-severe VF in NHPT (odds ratio [OR] 1.04, 95% confidence interval [CI] 0.25-4.55), while PHPT had an increased risk (OR 3.81,95% CI 1.15-15.12). Seventy-nine percent of NHPT and 59% of PHPT patients fulfilled the criteria for asymptomatic hyperparathyroidism. The biochemical phenotype of NHPT is intermediate between PHPT and controls. In contrast, the bone phenotype resembles controls with normal bone turnover, no significant BMD impairment, and no increased risk of VF.

Identifiants

pubmed: 32271382
pii: 5818374
doi: 10.1210/clinem/dgaa174
pii:
doi:

Substances chimiques

Biomarkers 0
Parathyroid Hormone 0
Vitamin D 1406-16-2
25-hydroxyvitamin D A288AR3C9H
Calcium SY7Q814VUP

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© Endocrine Society 2020. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Auteurs

Andrea Palermo (A)

Unit of Endocrinology and Diabetes, University Campus Bio-Medico, Rome, Italy.

Anda Mihaela Naciu (AM)

Unit of Endocrinology and Diabetes, University Campus Bio-Medico, Rome, Italy.

Gaia Tabacco (G)

Unit of Endocrinology and Diabetes, University Campus Bio-Medico, Rome, Italy.

Stefania Falcone (S)

Unit of Endocrinology and Metabolic Diseases, CTO A. Alesini Hospital, University Tor Vergata, Rome, Italy.

Assunta Santonati (A)

Department of Endocrinology, San Giovanni Addolorata Hospital, Rome, Italy.

Daria Maggi (D)

Unit of Endocrinology and Diabetes, University Campus Bio-Medico, Rome, Italy.

Luca D'Onofrio (L)

Department of Experimental Medicine, Sapienza University of Rome, Rome, Italy.

Silvia Irina Briganti (SI)

Unit of Endocrinology and Diabetes, University Campus Bio-Medico, Rome, Italy.

Domenico Castellitto (D)

UOS Malattie Metaboliche, Santa Maria Goretti Hospital, Latina, Italy.

Alessandro Casini (A)

UOS Malattie Metaboliche, Santa Maria Goretti Hospital, Latina, Italy.

Claudio Pedone (C)

Geriatric Unit, University Campus Bio-Medico, Rome, Italy.

Diana Lelli (D)

Geriatric Unit, University Campus Bio-Medico, Rome, Italy.

Andrea Fabbri (A)

Unit of Endocrinology and Metabolic Diseases, CTO A. Alesini Hospital, University Tor Vergata, Rome, Italy.

John P Bilezikian (JP)

Department of Medicine, Division of Endocrinology, College of Physicians & Surgeons, Columbia University, New York, New York.

Nicola Napoli (N)

Unit of Endocrinology and Diabetes, University Campus Bio-Medico, Rome, Italy.

Paolo Pozzilli (P)

Unit of Endocrinology and Diabetes, University Campus Bio-Medico, Rome, Italy.

Silvia Manfrini (S)

Unit of Endocrinology and Diabetes, University Campus Bio-Medico, Rome, Italy.

Roberto Cesareo (R)

UOS Malattie Metaboliche, Santa Maria Goretti Hospital, Latina, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH